Vibrio cholerae is a Gram-negative bacterium that causes cholera, a severe diarrheal disease . V. cholerae O1 serogroup strains are further divided into Ogawa, Hikojima, and Inaba serotypes . The hflK gene encodes the HflK protein, a component that has been studied in the context of bacterial pathogenesis and Type VI secretion systems . Recombinant HflK protein is produced in a laboratory setting using genetic engineering techniques, often in E. coli, to facilitate research on its structure, function, and interactions .
Recombinant Vibrio cholerae serotype O1 Protein HflK (hflK) is a full-length protein (1-395 amino acids) with a His-tag, expressed in E. coli .
| Characteristic | Description |
|---|---|
| Source | E. coli |
| Tag | His-tag (N-terminal) |
| Protein Length | Full Length (1-395 amino acids) |
| Form | Lyophilized powder |
| Purity | Greater than 90% as determined by SDS-PAGE |
| AA Sequence | MAWNEPGNNNGNNGRDNDPWGNNNRGNKGGRDQGPPDLDEVFNKLSQKLGGKFGGKGGKGPSFSGGGAIGFGVIAAIAVAVWFFTGFYTIGEAERGVVLRLGKYDRIVDPGLNWRPRFIDEVTPVNVQAIRSLRASGLMLTKDENVVTVSMDVQYRIADPYKYLYRVTNADDSLRQATDSALRAVVGDSLMDSILTSGRQQIRQSTQQTLNQVIDSYDMGLMIVDVNFQSARPPEQVKDAFDDAIAAREDEERFIREAEAYKNEILPKATGRAERLKKEAQGYNERTINEALGQVAQFEKLLPEYQAAPKVTRDRLYLDAMEQVYSNTSKVLIDSESSGNLLYLPIDKLAGQDNKTAQPRPNKSSSAYDQIELESQTTETNTDTQSRSTTRQGRY |
| Gene Name | hflK |
| Synonyms | hflK; VC_0349; Protein HflK |
| UniProt ID | Q9KV09 |
| Storage | Store at -20°C/-80°C upon receipt, aliquoting is necessary for multiple use. Avoid repeated freeze-thaw cycles. |
| Storage Buffer | Tris/PBS-based buffer, 6% Trehalose, pH 8.0 |
| Reconstitution | Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. |
HflK is involved in the Type VI secretion system (T6SS) in V. cholerae . The T6SS is a protein secretion system crucial for Gram-negative bacteria, facilitating interactions between bacteria and their environment . Specifically, HflK, along with other proteins, forms part of the membrane complex required for the assembly and function of the T6SS apparatus.
V. cholerae O1 strains can express Hcp, a T6SS component, with expression being growth phase dependent . The expression of Hcp is regulated by quorum sensing regulators HapR and LuxO, as well as the cAMP-CRP global transcriptional regulatory complex, and requires the RpoN sigma factor .
Non-O1/O139 V. cholerae strains possess genes related to pathogen-host interaction, including T3SS, virulence regulatory factors, transcriptional regulators, and two-component response regulator-related genes . Understanding the molecular mechanisms of pathogenicity and antibiotic resistance in non-O1/O139 V. cholerae strains is vital for developing effective prevention and treatment strategies .
Recombinant HflK protein is utilized in various research applications:
Structural Studies: To determine the three-dimensional structure of the protein, providing insights into its function .
Interaction Studies: To identify binding partners and understand its role within the T6SS complex .
Vaccine Development: As a potential target for vaccine development, contributing to the creation of new strategies to combat V. cholerae infections .
KEGG: vch:VC0349
STRING: 243277.VC0349
Unlike global regulators such as H-NS that directly affect transcription of virulence genes like rfbT , or Hfq which modulates gene expression post-transcriptionally through RNA binding , HflK likely functions at the protein level. While Hfq is essential for Vibrio cholerae virulence and suckling mouse intestine colonization , and proteins like LPLUNC1 modulate innate immune responses , the specific regulatory role of HflK in Vibrio cholerae pathogenesis requires further investigation.
The most established system for recombinant HflK production is E. coli expression with an N-terminal His-tag. This approach has been successfully used to produce the full-length protein (amino acids 1-395) with proper folding and functionality . When designing expression constructs, researchers should consider:
| Expression Parameter | Recommended Condition | Rationale |
|---|---|---|
| Host strain | E. coli BL21(DE3) or similar | Reduced protease activity, high expression |
| Vector | pET series with T7 promoter | Tight control of expression |
| Fusion tag | N-terminal His-tag | Facilitates purification while maintaining function |
| Induction | 0.5-1.0 mM IPTG | Balance between yield and solubility |
| Growth temperature | 16-25°C post-induction | Reduces inclusion body formation |
For optimal reconstitution of lyophilized HflK protein, follow these methodological steps:
Briefly centrifuge the vial containing lyophilized HflK protein to bring contents to the bottom.
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL.
Add glycerol to a final concentration of 5-50% (with 50% being optimal for long-term storage).
Aliquot the reconstituted protein to minimize freeze-thaw cycles.
Avoid repeated freeze-thaw cycles as they significantly reduce protein activity. Working aliquots may be stored at 4°C for up to one week .
Based on sequence analysis and structural predictions, HflK contains transmembrane domains that anchor it to the bacterial membrane. The presence of these hydrophobic regions requires careful consideration in experimental design:
For structural studies, detergent screening is necessary to identify optimal solubilization conditions.
When designing functional assays, maintaining the native membrane environment or using appropriate membrane mimetics is crucial.
If studying interactions with other proteins, consider whether interactions occur in membrane-proximal regions or cytoplasmic domains.
While direct evidence linking HflK to specific virulence pathways is limited, several hypothetical mechanisms can be proposed based on knowledge of related systems:
HflK may function in quality control of membrane proteins involved in virulence factor secretion or surface presentation.
It could potentially interact with regulatory networks controlled by global regulators like H-NS, which is known to repress serotype conversion through rfbT regulation .
HflK might indirectly influence virulence by affecting stress responses, similar to how the alternative sigma factor σE controls approximately half the genes upregulated in an hfq mutant .
Experimental approaches to test these hypotheses would include co-immunoprecipitation studies, comparative proteomics of wildtype versus hflK mutants, and virulence assays in animal models.
Developing a reliable hflK knockout model requires careful consideration of genetic tools and phenotypic validation:
Construction approaches:
Allelic exchange using suicide vectors (e.g., pCVD442)
CRISPR-Cas9 mediated genome editing
Transposon mutagenesis screening
Validation methods:
PCR verification of the deletion
RT-qPCR to confirm absence of transcript
Western blotting to verify protein absence
Complementation studies to confirm phenotype specificity
Phenotypic characterization:
Growth curves under various stress conditions
Membrane integrity assays
Virulence factor expression analysis
Animal colonization models
When analyzing phenotypes, compare results to other regulatory mutants (e.g., hns or hfq) to contextualize the role of HflK within Vibrio cholerae virulence networks .
Serotype switching between Ogawa and Inaba in Vibrio cholerae involves the rfbT gene, which encodes a methyltransferase responsible for O-antigen methylation . While current research shows H-NS directly represses rfbT transcription, the potential role of HflK in serotype switching requires investigation through:
Comparative analysis of rfbT expression and methyltransferase activity in wildtype vs. hflK mutant strains
Assessment of O-antigen structure in hflK mutants using mass spectrometry
Epistasis studies combining hflK mutations with other regulatory mutations (e.g., hns)
Analysis of HflK expression during environmental transitions that might trigger serotype switching
This research direction could reveal whether HflK functions in post-translational regulation of RfbT or other components of the O-antigen biosynthesis pathway.
Given that other regulatory proteins like Hfq influence alternative sigma factors such as σE , investigating HflK's potential role in stress response networks could provide valuable insights:
Transcriptomic approach: Compare gene expression profiles between wildtype and hflK mutant strains under various stress conditions (oxidative stress, acid stress, bile exposure)
Proteomic analysis: Identify proteins with altered abundance or post-translational modifications in hflK mutants
Epistasis studies: Create double mutants (hflK/σE pathway components) to determine functional relationships
In vivo relevance: Assess colonization efficiency and competitive index of hflK mutants in animal models
Understanding HflK's role in stress response networks could reveal novel connections between membrane protein quality control and virulence regulation in Vibrio cholerae.
Advanced structural characterization of HflK could potentially identify unique features that might be exploited for antimicrobial development:
Cryogenic electron microscopy of the full HflK complex in membrane environments
Hydrogen-deuterium exchange mass spectrometry to map dynamic regions
Fragment-based screening to identify small molecules that disrupt HflK function
In silico docking studies based on resolved structures
If HflK proves essential for Vibrio cholerae virulence or stress adaptation, these structural insights could guide the development of novel antimicrobial approaches targeting protein-protein interactions within the HflK complex.